>peptide 1 (29 aa)
MHLANFIHQTTVMSSPMMQSLQLVQTSNQ*
>peptide 2 (30 aa)
MRRTSLPLRGSQSKGGSPKCTKHTEDIKIS*
>peptide 3 (101 aa)
MASSATLLHHYSPRPSISSNSSSSSSSSSASSSSSSSSFDQRRCFNWKFLCFSGCIGWTIQGVRWQTTQGVKRERGEQLRRKECNGFCANISFTFETLVS
T*
>peptide 4 (33 aa)
MMENLYQRLVLSNGVFFMLMSLMIIWSVGVHHL*
>peptide 5 (386 aa)
MGTTEGSVMSPKVLTDTGDEPEHLLVLVHGILASPSDWTYVQAELRRRLGRNFLIYASSCNTFTKTFTGIDGAGKRLADEVRLVVKKKESLKKISFLAHS
LGGLIARYALGELYSSDNCNEQSNDAVTSTSANLKPVGSLDIGLIAGLEPVNFITLATPHLGVRGKNQLPFLFGLPILEKLAAPIAPIFVGQTGSQLFLT
DGKPTKPPLLLRMASDCDDGKFISALGAFKWRVLYANVSYDHMVGWRTSSIRRVTELVKPPWRSLDGYKHVVDVEYCPPASCEGPHYPLEAAKAKEAAQN
APSTQRTLKYHESMEEEMIRGLQQLGWKKIDVSFHSAFWPFFAHNNIHVKNEFFHNAGVGVIAHVADHIKQQEKQPESSSLITPSL*
>CNT0008225
AGAAAAGAAAAAACAACAAAAATGGAATTAGGAAAACGCCAACTACCCCTTTTTAGCTCTTTCTGAGTAGAAGAAGCTTCGTTGAGTTCAACATCAATGT
CTAGTAAAAAGCAGAGGAGGATGTTGAAAGTAAGGAAAAATGGTGGGTGTGATGTTGACATAACACACTCTGCTTAGATTGATTTGCGCGGAGGAAAAGG
AAAACAACAAAGACAATCCCCAAAGGGTCCTCTTCTCTTTCTACACTTGTTGGGTTATCCCATAGCCATATATAGCCATATATATGGCGTCATCAGCGAC
ATTACTTCATCATTATTCTCCTCGCCCTTCTATCTCTTCCAATTCTTCTTCTTCTTCTTCATCATCTTCTGCTTCTTCTTCGTCATCTTCTTCCTCTTTT
GATCAACGACGATGCTTTAATTGGAAATTTCTCTGCTTTTCTGGATGTATAGGATGGACAATTCAAGGTGTAAGGTGGCAAACAACTCAAGGTGTAAAGC
GTGAAAGGGGTGAACAACTAAGGCGTAAAGAGTGCAATGGATTTTGTGCGAATATTAGCTTCACCTTTGAGACATTGGTCAGCACATAGGGATAAACAAC
ATCTGTAGAAGTCAAAGCTTTAGAGCCCATGCAATGGGTACAACTGAAGGAAGTGTTATGTCTCCGAAAGTCTTGACAGATACGGGGGATGAACCTGAAC
ATCTTCTAGTCCTTGTTCATGGCATCTTAGCAAGCCCAAGTGACTGGACGTATGTACAAGCAGAGTTGAGAAGGCGGTTGGGAAGAAACTTTTTGATATA
TGCAAGTTCATGTAATACGTTCACTAAAACCTTCACTGGGATTGATGGAGCTGGGAAACGACTAGCAGATGAAGTCAGGCTGGTTGTAAAGAAGAAAGAA
AGCCTGAAGAAGATATCCTTTTTAGCTCATTCTCTTGGTGGATTGATTGCAAGATATGCACTTGGCGAACTTTATTCATCAGACAACTGTAATGAGCAGT
CCAATGATGCAGTCACTTCAACTAGTGCAAACCTCAAACCAGTAGGCTCCTTAGATATAGGATTGATTGCTGGCCTGGAGCCAGTCAATTTTATCACCTT
GGCAACACCACATCTTGGTGTGAGAGGGAAAAATCAGCTTCCTTTTCTCTTTGGGTTGCCAATCTTGGAGAAACTTGCAGCACCTATAGCTCCTATATTT
GTTGGTCAAACTGGTAGTCAGCTCTTCCTTACAGATGGCAAACCTACTAAACCACCTCTTTTGTTAAGGATGGCATCAGACTGTGATGATGGAAAATTTA
TATCAGCGCTTGGTGCTTTCAAATGGCGTGTTCTTTATGCTAATGTCTCTTATGATCATATGGTCGGTTGGCGTACATCATCTATAAGAAGGGTGACAGA
ACTTGTCAAGCCCCCTTGGCGATCTTTGGATGGCTACAAACATGTAGTAGATGTGGAGTATTGTCCTCCAGCTTCATGCGAAGGACCTCATTACCCCTTA
GAGGCAGCCAAAGCAAAGGAGGCAGCCCAAAATGCACCAAGCACACAGAGGACATTAAAATATCATGAAAGTATGGAAGAGGAAATGATACGTGGCTTGC
AACAGTTGGGGTGGAAAAAAATTGATGTTAGCTTTCACTCAGCGTTCTGGCCCTTTTTTGCACATAACAATATCCATGTGAAGAATGAGTTTTTTCACAA
TGCTGGAGTAGGAGTAATTGCTCATGTCGCAGACCACATAAAGCAACAAGAGAAGCAACCTGAATCTTCCTCCTTAATTACCCCTAGCTTGTAACTCATA
TAGTTGTACAGAAAGCAATCCAGCATACATTTAAATGAAATCAAAACGCTATAATTGATTGGAAATGTATATTTTTCTGAACACTACTGGTTTACTTGGT
TATAAGCCAGGTTTTTCGTTAAGCATATTCAAGATATATGTATAGTGATATGATTTTTGGTGAAGGGTGTTTAATTGACCACCCTTTGCTCCGTCACCAG
TTTCAATAGGAAGACTGTTGATGTTAGCATTGTACCCTGTATTGGTTGTTATCTATGACATATTATGTGATTTGCTCTTTTCCGTGTTCG
Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
---|---|---|---|---|---|---|---|---|
PGSC0003DMT400085240 | NADH-ubiquinone oxidoreductase chain 4 | protein coding | CNT0008225 | 89 | 74 | CDS | Trans | |
PGSC0003DMT400091836 | Gene of unknown function | protein coding | CNT0008225 | 104 | 74 | CDS | Trans |